Emmaus Life Sciences, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

EMMA

organization

SIC: 2834

SEC Insider

$404.0M

894 transactions

Summary

Emmaus Life Sciences, Inc. (EMMA) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $11.7MSales: $2K40 insiders

Date	Insider	Type	Value
2023-12-15	Lim Seah H.	J	$1.3M
2023-12-15	ZEN Wei Peu	J	$1.1M
2024-02-01	LEE WILLIS C(Co-President & COO)	A	$30K
2024-02-01	NAGASAKI YASUSHI(CFO)	A	$30K
2024-02-01	Sekulich George(Co-President & CCO)	A	$30K
2024-02-01	Stark Charles William(CSO & EVP Clinical Development)	A	$30K
2024-02-01	Lim Seah H.	A	$15K
2024-02-01	ZEN Wei Peu	A	$15K
2024-02-01	Zwicker Ian Harvey	A	$15K
2024-02-29	LEE WILLIS C(Co-President & COO)	Buy	$10K
2023-11-30	LEE WILLIS C(COO)	Buy	$7K
2024-02-28	LEE WILLIS C(Co-President & COO)	Buy	$2K
2023-12-20	Lim Seah H.	Sell	$2K
2024-02-26	LEE WILLIS C(Co-President & COO)	Buy	$2K
2024-02-27	LEE WILLIS C(Co-President & COO)	Buy	$1K
2023-11-30	LEE WILLIS C(COO)	Buy	$890.04
2024-09-16	Lim Seah H.	Buy	$800
2023-12-15	Lim Seah H.	Sell	$660
2023-11-29	LEE WILLIS C(COO)	Buy	$519
2023-12-15	Lim Seah H.	J	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Emmaus Life Sciences, Inc. — Contributions, Lobbying & Contracts | Poliscope